1
/
of
1
Dabitrin (Dabigatran Etexilate Mesilate)
Dabitrin (Dabigatran Etexilate Mesilate)
Regular price
₱1,910.00 PHP
Regular price
Sale price
₱1,910.00 PHP
Unit price
₱63.67 each
Taxes included.
Quantity
Couldn't load pickup availability
Dabitrin (Dabigatran Etexilate Mesilate) is an oral anticoagulant medication used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. This direct thrombin inhibitor works by selectively inhibiting both free and clot-bound thrombin, preventing the formation of blood clots without requiring routine monitoring.
Dabigatran etexilate mesilate is prescribed for patients who need long-term anticoagulation therapy and offers a fixed-dose alternative to warfarin-based regimens. The medication is typically available in capsule form and is absorbed in the gastrointestinal tract, where it is converted to dabigatran, the active metabolite.
Key considerations include adherence to prescribed dosing schedules, awareness of potential drug interactions, and monitoring for signs of bleeding. Dabitrin is contraindicated in patients with mechanical heart valves and requires careful evaluation in those with renal impairment or active bleeding disorders. Common side effects may include dyspepsia and gastrointestinal discomfort.
This anticoagulant is suitable for patients seeking an alternative to warfarin who require consistent anticoagulation without frequent laboratory testing. Always take as directed by your healthcare provider and report any unusual bleeding, bruising, or adverse effects immediately.
Dabigatran etexilate mesilate is prescribed for patients who need long-term anticoagulation therapy and offers a fixed-dose alternative to warfarin-based regimens. The medication is typically available in capsule form and is absorbed in the gastrointestinal tract, where it is converted to dabigatran, the active metabolite.
Key considerations include adherence to prescribed dosing schedules, awareness of potential drug interactions, and monitoring for signs of bleeding. Dabitrin is contraindicated in patients with mechanical heart valves and requires careful evaluation in those with renal impairment or active bleeding disorders. Common side effects may include dyspepsia and gastrointestinal discomfort.
This anticoagulant is suitable for patients seeking an alternative to warfarin who require consistent anticoagulation without frequent laboratory testing. Always take as directed by your healthcare provider and report any unusual bleeding, bruising, or adverse effects immediately.
Share
